Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 518.50
Bid: 517.50
Ask: 519.00
Change: -7.50 (-1.43%)
Spread: 1.50 (0.29%)
Open: 526.50
High: 527.00
Low: 516.00
Prev. Close: 526.00
DRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LTIP 2021 – EPS Performance Condition

9 Aug 2021 11:13

RNS Number : 0135I
Drax Group PLC
09 August 2021
 

9 August 2021

Drax Group plc

("Drax" or the "Company"; Symbol: DRX)

 

LTIP 2021 - EPS Performance Condition

 

In the Annual Report and Financial Statements of Drax Group plc for the financial year ended 31 December 2020, ('the Annual Report'), the Company explained that the Cumulative Adjusted Earnings Per Share target ('EPS'), which is one of the two performance conditions to determine vesting in respect of the grants made under the Long Term Incentive Plan ('LTIP'), would be finalised and subsequently announced via RNS after completion of the proposed acquisition of Pinnacle Renewable Energy Inc. ('Pinnacle'). Targets have been set which took account of the Company's budget approved in January, prevailing market expectations and performance of sector peers at that point in time, however finalisation was delayed in order that the targets could reflect the impact of the proposed acquisition of Pinnacle.

Subsequent to the completion of the Pinnacle acquisition in April 2021, a fair value assessment of the acquired assets has been undertaken, details of which were included in the Company's Half Year Report, issued on Thursday 29 July.

Following a meeting of the Remuneration Committee in July 2021 and the announcement of the Company's Half Year results, the proposed EPS target for the 2021 Grants has now been finalised, taking account of Pinnacle.

The vesting of awards granted in 2021 ('the 2021 Grants') shall be subject to satisfying two performance conditions over the financial years 2021, 2022 and 2023. 50% of the 2021 Grants will be measured based on Total Shareholder Return relative to the FTSE 350, and the remaining 50% will be measured based on EPS. This is in line with the current Remuneration Policy for the Company.

The targets for the EPS performance condition will be as set forth below. The threshold level, based on general practice, is set at 90% of the target level. Vesting between the threshold and maximum will be on a straight-line basis.

BASIS OF VESTING

Performance

Level of Cumulative

Adjusted EPS

Percentage of Award Vesting(of EPS performance condition)

Below threshold

<104.9p

0%

Threshold

104.9p

25%

Maximum

128.2p

100%

The EPS target is 'Adjusted EPS', derived from Adjusted Results as reported in the Company's audited financial statements. Instances where such adjustments might apply include acquisition and restructuring costs, asset obsolescence charges, costs on debt restructuring, costs and credits arising from major transactions and certain remeasurements on derivative contracts. For more information on Adjusted Results applicable for 2020, see note 2.7 of the Annual Report.

There may arise circumstances during the performance period where adjustment or discretion is applied by the Remuneration Committee by reference to exceptional items and the Remuneration Policy. The application of such adjustments would be considered during and upon completion of the performance cycle.

In making their assessment, the Remuneration Committee will take into account appropriate advice (for example from the Company's independent auditors and the Remuneration Committee advisers) and also give due consideration to the shareholder experience and that of wider stakeholders. The Remuneration Committee would also take into account exceptional and unforeseen circumstances in assessing the appropriate level of vesting judged against the performance of the Company and management at the end of the performance period.

With regard to the relative Total Shareholder Return measure, 25% of the Award will vest for median performance rising on a straight line basis to 100% vesting for upper quartile performance.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKARRAUUWRAR
Date   Source Headline
30th Apr 20243:17 pmRNSHolding(s) in Company
30th Apr 20243:08 pmRNSHolding(s) in Company
25th Apr 20242:01 pmRNSResult of AGM
25th Apr 20247:00 amRNSTrading Update
24th Apr 20243:33 pmRNSHolding(s) in Company
23rd Apr 202410:34 amRNSHolding(s) in Company
19th Apr 202410:32 amRNSNotice of Redemption
18th Apr 20245:01 pmRNSPricing of offering of Senior Secured Notes
17th Apr 20249:00 amRNSDirector/PDMR Shareholding
16th Apr 202410:54 amRNSFixed income investor calls
15th Apr 20249:35 amRNSHolding(s) in Company
8th Apr 20244:54 pmRNSHolding(s) in Company
5th Apr 20243:48 pmRNSBlock listing Interim Review
5th Apr 20243:47 pmRNSBlock listing Interim Review
5th Apr 20243:42 pmRNSBlock listing Interim Review
5th Apr 20248:00 amRNSDirector/PDMR Shareholding
4th Apr 20245:11 pmRNSHolding(s) in Company
4th Apr 202410:18 amRNSTotal Voting Rights
4th Apr 20247:00 amRNSNew £150 million term-loan facility
3rd Apr 202410:15 amRNSHolding(s) in Company
28th Mar 20243:05 pmRNSHolding(s) in Company
25th Mar 20243:48 pmRNSHolding(s) in Company
25th Mar 20248:45 amRNSAdditional Listing
22nd Mar 202410:54 amRNSHolding(s) in Company
21st Mar 20248:00 amRNSMailing of Annual Report and Notice of AGM
18th Mar 20242:04 pmRNSHolding(s) in Company
18th Mar 202410:30 amRNSDirector/PDMR Shareholding
15th Mar 20242:51 pmRNSHolding(s) in Company
14th Mar 20241:37 pmRNSHolding(s) in Company
11th Mar 202412:26 pmRNSHolding(s) in Company
8th Mar 20244:07 pmRNSHolding(s) in Company
6th Mar 20242:46 pmRNSHolding(s) in Company
4th Mar 20243:35 pmRNSTotal Voting Rights
4th Mar 20243:18 pmRNSHolding(s) in Company
1st Mar 20242:38 pmRNSHolding(s) in Company
29th Feb 20247:04 amRNSNon-Executive Director standing down
29th Feb 20247:00 amRNSAnnual Financial Report
28th Feb 20247:00 amRNSCapacity Market Agreements
27th Feb 20249:20 amRNSHolding(s) in Company
23rd Feb 20244:32 pmRNSHolding(s) in Company
22nd Feb 202412:46 pmRNSNotice of Results
21st Feb 20249:32 amRNSHolding(s) in Company
15th Feb 202410:51 amRNSHolding(s) in Company
13th Feb 202412:47 pmRNSHolding(s) in Company
7th Feb 202410:32 amRNSHolding(s) in Company
1st Feb 202411:56 amRNSTotal Voting Rights
31st Jan 20243:16 pmRNSHolding(s) in Company
30th Jan 20242:15 pmRNSHolding(s) in Company
30th Jan 20248:45 amRNSAdditional Listing
29th Jan 20243:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.